JKIL.NSE News

J. Kumar Infraprojects has received Letters of Acceptance worth Rs 2,487.65 crores for multiple infrastructure projects in Mumbai. The contracts include metro connectivity work and major road and bridge construction awarded by Mumbai Metro Rail Corporation and MCGM. With execution timelines of up to 42 months, the projects strengthen the company’s urban infrastructure portfolio.

The latest update is out from J. Kumar Infraprojects Limited ( ($IN:JKIL) ). J. Kumar Infraprojects Limited has received letters of acceptance for ...

J Kumar Infraprojects has secured a Rupees 1,184 crore EPC contract for constructing an international exhibition-cum-convention centre in Lucknow. The project, awarded by the Superintending Engineer, PMGSY Circle P.W.D., will accommodate 10,000 people and is scheduled for completion within 24 months. The contract strengthens the company’s infrastructure portfolio.

J. Kumar Infraprojects won a Rs 1,184 crore EPC contract to build a 10,000-capacity convention centre in Lucknow. Despite this, the stock has fallen nearly 29 percent in six months. The order may boost sentiment, with investors watching for recovery in performance and future growth outlook.

J Kumar Infraprojects Limited, through its joint venture J. Kumar-SDPL (JV), has received a Letter of Acceptance from the National Highways Authority of India for a Rupees 2,360 crore expressway project in Maharashtra. The project involves constructing a 32.180 km 4-lane expandable highway connecting Vadhavan Port to NH 48, with execution scheduled over 30 months.

In this briefing: Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive 1. Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Sequential Margin Gains with Upside from Volume Recovery: Automotive Axle Ltd. (AAL) delivered a steady improvement in profitability, with EBITDA margins rising to 11.4% in Q3FY26, up from 10.5% in the preceding quarter and 10.8% in the corresponding period last year, reflecting effective cost management and an improved product mix. Management remains confident of achieving mid-teen EBITDA margins (13%+) in the near term, contingent on a recovery in market volumes. With higher capacity utilization and better fixed cost absorption expected in Q4FY26 and FY27, operating leverage is likely to further support margin expansion and sustain the upward trajectory in profitability Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive 1. Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Sequential Margin Gains with Upside from Volume Recovery: Automotive Axle Ltd. (AAL) delivered a steady improvement in profitability, with EBITDA margins rising to 11.4% in Q3FY26, up from 10.5% in the preceding quarter and 10.8% in the corresponding period last year, reflecting effective cost management and an improved product mix. Management remains confident of achieving mid-teen EBITDA margins (13%+) in the near term, contingent on a recovery in market volumes. With higher capacity utilization and better fixed cost absorption expected in Q4FY26 and FY27, operating leverage is likely to further support margin expansion and sustain the upward trajectory in profitability Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive 1. Automotive Axles Ltd - Sequential Margin Upswing with Volume-Led Upside Sequential Margin Gains with Upside from Volume Recovery: Automotive Axle Ltd. (AAL) delivered a steady improvement in profitability, with EBITDA margins rising to 11.4% in Q3FY26, up from 10.5% in the preceding quarter and 10.8% in the corresponding period last year, reflecting effective cost management and an improved product mix. Management remains confident of achieving mid-teen EBITDA margins (13%+) in the near term, contingent on a recovery in market volumes. With higher capacity utilization and better fixed cost absorption expected in Q4FY26 and FY27, operating leverage is likely to further support margin expansion and sustain the upward trajectory in profitability Content is external broker report sourced from online content aggregator through publicly available sources and is displayed below for general informational purposes only.

In this briefing: Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact KNR Constructions Ltd - Weak Revenue and Margin Visibility; SELL J Kumar Infraprojects Ltd - Execution Is Key for Pick-Up in Revenue Growth; Retain BUY Tata Steel Ltd - Q3: Largely Inline; Europe Policy Reset Structurally Supportive Aditya Birla Fashion & Retail Ltd. - New Businesses Offset Cyclical Softness; Maintain HOLD 1. Max Healthcare Institute Ltd - Short-Term Disruptions; Multi-Year Growth Intact Revenue Growth Moderates: Max Healthcare reported net revenue of Rs 2,484 Cr, up 9% YoY but down 3.7% QoQ, moderately below expectations. Performance was supported by stable ARPOB; however, revenues were impacted by (1) lower incidence of borne diseases affecting occupancy, (2) temporary substitution of Standalone Health Insurer (SAHI) patients with PSU beneficiaries due to disruption in cashless services (largely resolved toward quarter-end), and (3) discontinuation of high-value patented chemotherapy drugs following restrictive CGHS pricing guidelines.